By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tocagen Inc. 

3030 Bunker Hill Street
Suite 230
San Diego  California  92109  U.S.A.
Phone: 858-412-8400 Fax: 858-412-8499


Company News
Complementary Preclinical Studies Published In Neuro-Oncology Demonstrate Immune Activation Mechanism Of Tocagen's Toca 511 & Toca FC 6/19/2017 8:13:47 AM
BIO2017: After IPO, Full Speed Ahead for San Diego’s Tocagen 6/16/2017 8:54:22 AM
Tocagen Reports First Quarter 2017 Financial And Business Results 5/24/2017 8:54:34 AM
Tocagen Presents Data At The American Society of Gene Therapy 20th Annual Meeting 5/11/2017 8:01:43 AM
Tocagen Announces Closing Of Initial Public Offering And Exercise Of The Underwriters' Option 4/20/2017 7:32:02 AM
Tocagen Announces Pricing Of Initial Public Offering 4/13/2017 9:07:08 AM
Investors Ready for Brain Cancer Biotech Tocagen's Upcoming IPO This Wednesday 4/11/2017 7:00:42 AM
San Diego's Tocagen Goes for $86 Million IPO 3/10/2017 7:44:20 AM
Tocagen Appoints Mark Foletta As Executive Vice President And Chief Financial Officer 3/7/2017 7:38:38 AM
Tocagen Receives Breakthrough Therapy Designation From FDA For Toca 511 & Toca FC In Recurrent High Grade Glioma 2/23/2017 6:40:54 AM